Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization
Peter T. Doohan, Lachlan Oldfield, Jonathon C. Arnold, et al.
The AAPS Journal (2021) Vol. 23, Iss. 4
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and cannabidiol metabolism in a cohort of unselected oral cannabis users
Jessica Wright, Linda Huang, Basant E. Katamesh, et al.
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
Bahareh Abd‐Nikfarjam, Amirhossein Dolati‐Somarin, Vafa Baradaran Rahimi, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 560-583
Closed Access | Times Cited: 24
Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions
Rosemary T. Smith, Staci A. Gruber
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 22
Drug interactions in a sample of inpatients diagnosed with cannabis use disorder
Martin Schulze Westhoff, Christina Massarou, Stefan Bleich, et al.
Journal of Neural Transmission (2025)
Open Access | Times Cited: 1
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review
Eman A. Alraddadi, Faisal F. Aljuhani, Ghadah Y. Alsamiri, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial
Mary Kathryn Dahlgren, Ashley M. Lambros, Rosemary T. Smith, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 30
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)
Eduardo Rodriguez Almaraz, Nicholas Butowski
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 1, pp. 30-44
Open Access | Times Cited: 16
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
Lyndsey L. Anderson, Maia G. Etchart, Dilara Bahceci, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Herb–Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements
Annemarie Lippert, Bertold Renner
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1567-1567
Open Access | Times Cited: 23
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
Rahul Nachnani, Amy Knehans, Jeffrey D. Neighbors, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ9‐Tetrahydrocannabinol Without Improving Its Analgesic Properties
Andriy A. Gorbenko, Jules A. A. C. Heuberger, Linda E. Klumpers, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 5, pp. 1289-1303
Open Access | Times Cited: 5
Utilization of Cannabidiol in Post-Organ-Transplant Care
Sachiko Koyama, Jumar Etkins, Jin-Sun Jun, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 699-699
Open Access
The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications
Aaron P. Jones, Ali S. Taha, Grover P. Miller
Neuroscience & Biobehavioral Reviews (2025), pp. 106043-106043
Closed Access
Plasma Protein Binding, Biostability, Metabolite Profiling, and CYP450 Phenotype of TPB15 Across Different Species: A Novel Smoothened Inhibitor for TNBC Therapy
Dingsheng Wen, Bo‐Yu Chen, Mingqi Deng, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 423-423
Open Access
Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy
Keti Bardhi, Shelby Coates, Christy J. W. Watson, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1443-1460
Open Access | Times Cited: 21
Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
Yolanda Paes-Colli, Andrey F. L. Aguiar, Alinny Rosendo Isaac, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Review of the Use of Medicinal Cannabis Products in Palliative Care
James Troyer, Kimberson Tanco
Cancers (2024) Vol. 16, Iss. 7, pp. 1412-1412
Open Access | Times Cited: 4
Effects of cannabidiol and Δ 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review
Sarah A. Smith, Gia Han Le, Kayla M. Teopiz, et al.
Drug Metabolism Reviews (2024) Vol. 56, Iss. 2, pp. 164-174
Closed Access | Times Cited: 4
Therapeutic potential of CBD in Autism Spectrum Disorder
João Francisco Cordeiro Pedrazzi, Lucas Hassib, Frederico Rogério Ferreira, et al.
International review of neurobiology (2024), pp. 149-203
Closed Access | Times Cited: 4
7-Hydroxycannabidiol and 7-carboxycannabidiol induced cytotoxicity via apoptosis and endoplasmic reticulum stress in human hepatic cells
Yuxi Li, Xilin Li, Qiangen Wu, et al.
Archives of Toxicology (2025)
Closed Access
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
Pradeepraj Durairaj, Zixiang Liu
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 44-44
Open Access
Acute cannabis intoxication among the paediatric population
Ginevra Malta, Giuseppe Albano, Gianluca Lavanco, et al.
Frontiers in Toxicology (2025) Vol. 7
Open Access
A survey of medical cannabis use during perimenopause and postmenopause
Mary Kathryn Dahlgren, Celine El-Abboud, Ashley M. Lambros, et al.
Menopause The Journal of The North American Menopause Society (2022) Vol. 29, Iss. 9, pp. 1028-1036
Open Access | Times Cited: 16
Cannabidiol drug interaction considerations for prescribers and pharmacists
Myfanwy Graham, Jennifer Martin, Catherine Lucas, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1383-1397
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top